A detailed history of Capital Investment Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 3,140 shares of NVS stock, worth $308,819. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,140
Previous 3,214 2.3%
Holding current value
$308,819
Previous $342,000 5.56%
% of portfolio
0.04%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$106.13 - $120.89 $7,853 - $8,945
-74 Reduced 2.3%
3,140 $361,000
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $1,481 - $1,717
-16 Reduced 0.5%
3,214 $342,000
Q1 2024

Apr 25, 2024

SELL
$95.27 - $108.47 $5,906 - $6,725
-62 Reduced 1.88%
3,230 $312,000
Q4 2023

Feb 01, 2024

SELL
$92.27 - $101.54 $29,803 - $32,797
-323 Reduced 8.93%
3,292 $332,000
Q3 2023

Nov 02, 2023

SELL
$94.73 - $105.13 $5,873 - $6,518
-62 Reduced 1.69%
3,615 $368,000
Q2 2023

Jul 28, 2023

BUY
$92.52 - $104.91 $13,970 - $15,841
151 Added 4.28%
3,677 $371,000
Q1 2023

Apr 21, 2023

SELL
$80.03 - $92.81 $57,141 - $66,266
-714 Reduced 16.84%
3,526 $324,000
Q4 2022

Feb 03, 2023

SELL
$75.55 - $92.52 $7,555 - $9,252
-100 Reduced 2.3%
4,240 $384,000
Q3 2022

Oct 26, 2022

SELL
$74.61 - $87.26 $21,189 - $24,781
-284 Reduced 6.14%
4,340 $330,000
Q2 2022

Jul 22, 2022

BUY
$80.52 - $93.75 $2,254 - $2,625
28 Added 0.61%
4,624 $391,000
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $10,093 - $11,418
126 Added 2.82%
4,596 $403,000
Q4 2021

Feb 01, 2022

SELL
$79.7 - $88.13 $7,890 - $8,724
-99 Reduced 2.17%
4,470 $391,000
Q3 2021

Oct 28, 2021

BUY
$81.78 - $95.14 $12,675 - $14,746
155 Added 3.51%
4,569 $374,000
Q2 2021

Jul 27, 2021

SELL
$85.24 - $94.15 $10,655 - $11,768
-125 Reduced 2.75%
4,414 $403,000
Q1 2021

May 05, 2021

SELL
$83.5 - $98.47 $16,616 - $19,595
-199 Reduced 4.2%
4,539 $388,000
Q4 2020

Jan 25, 2021

BUY
$78.07 - $94.43 $7,026 - $8,498
90 Added 1.94%
4,738 $447,000
Q3 2020

Oct 19, 2020

SELL
$82.14 - $91.0 $30,473 - $33,761
-371 Reduced 7.39%
4,648 $404,000
Q2 2020

Aug 05, 2020

BUY
$80.93 - $91.1 $26,625 - $29,971
329 Added 7.01%
5,019 $438,000
Q1 2020

Apr 28, 2020

BUY
$70.67 - $99.01 $2,120 - $2,970
30 Added 0.64%
4,690 $387,000
Q4 2019

Feb 04, 2020

BUY
$84.35 - $95.37 $28,847 - $32,616
342 Added 7.92%
4,660 $441,000
Q3 2019

Oct 17, 2019

SELL
$85.54 - $94.26 $1,539 - $1,696
-18 Reduced 0.42%
4,318 $375,000
Q2 2019

Aug 08, 2019

BUY
$75.4 - $92.8 $236,379 - $290,928
3,135 Added 261.03%
4,336 $408,000
Q4 2018

Feb 04, 2019

BUY
$73.66 - $82.02 $88,465 - $98,506
1,201 New
1,201 $103,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.